Evaluation of the Response to Hypoxia at Rest and During Exercise in a Healthy Subject After a Cryostimulation Exposure
CRYOX
1 other identifier
interventional
35
1 country
2
Brief Summary
Many information is available regarding human adaptations to cold or hypoxia. Adaptations to these environments and physical exercise constitute responses to physiological stress aimed at amplifying the organism's reactions and improving its performance. However, studies conducted so far to understand these adaptations and their underlying mechanisms have been organized in a dissociated manner, with each study focusing on only one of these specific situations (cold, hypoxia, or exercise). Understanding cross-adaptations is crucial, as human beings are often simultaneously exposed to several of these stimuli, and understanding this cross-exposure can be considered a prerequisite for pre-acclimatization strategies to these different environments. Cross-adaptations has been defined as follows: "It simply involves considering that long-term exposure (either continuous or intermittent) to a given unfavorable environment not only increases tolerance to that particular environment but also leads to gains or losses of tolerance to other unfavorable factors that the adapted organism had never encountered before." When specifically examining cross-adaptations to cold and hypoxia, only one study focusing on the human model is available. The lack of perspectives and positions regarding the results calls for further investigations. The main objective of this study is to assess the effect of repeated exposures to cryostimulation on the variation of the respiratory exchange ratio in hypoxia during exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
December 18, 2023
CompletedStudy Start
First participant enrolled
January 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2025
CompletedJanuary 26, 2024
December 1, 2023
1.1 years
December 8, 2023
January 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
variation of the respiratory quotient during exercise
respiratory exchange ratio will be measured continuously using a portable metabolic station to analyze gas exchanges
Comparing the average values obtained during exercise in hypoxia at baseline and after 15 days.
Study Arms (2)
Control Group
NO INTERVENTIONParticipants will not undergo cryostimulation exposure but will only receive 2 1-hour hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval
Cryostimulation Group
EXPERIMENTALParticipants will be exposed to cryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks and will undergo 2 hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval
Interventions
Cryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks.
Eligibility Criteria
You may qualify if:
- Having a high level of physical activity according to the criteria of the World Health Organization, assessed using the Global Physical Activity Questionnaire (GPAQ);
- No exposure to cryostimulation or hypoxia (FiO2 13.5%, equivalent to an altitude of 3500 m) in the last 90 days;
- No planned sports competition during the 4 weeks of the protocol;
- Maintaining a stable physical activity level (regular training, without interruption or specific competition, including sports training programs) anticipated for 4 weeks;
- No history of respiratory conditions (asthma, respiratory allergies, exercise-induced asthma, exertional dyspnea);
- Absence of any chronic medical condition;
- No ongoing medication treatments;
- Covered by a French Social Security;
- Informed consent, signed by the subject after clear and fair information about the study.
You may not qualify if:
- Subject under treatment;
- Simultaneous participation in another clinical research study;
- Individuals with enhanced protection, namely minors, individuals deprived of liberty by judicial or administrative decision, persons staying in a healthcare or social facility, adults under legal protection, and finally, patients in emergency situations;
- Subject presenting a contraindication to hypoxia and/or cryostimulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Laboratoire MOVE UR 20296 - Poitiers University
Poitiers, 86000, France
Clinical Investigation Centre INSERM CIC1402 - Poitiers University - CHU POITIERS
Poitiers, 86021, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2023
First Posted
December 18, 2023
Study Start
January 25, 2024
Primary Completion
February 25, 2025
Study Completion
May 25, 2025
Last Updated
January 26, 2024
Record last verified: 2023-12